SEC Form 4 · accession 0001127602-18-022829
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Felicia F Norwood
Officer — Exec VP & President, GBD
Period of report
Jul 2, 2018
Accepted (ET)
Jul 5, 2018 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 2, 2018 | A | 1,784 | $0.00 | A | 1,784 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $238.27 | Jul 2, 2018 | A | 7,516 | A | — | Jul 2, 2028 | Common Stock | 7,516 | 7,516 | D |
Explanation of responses
- F1Represents restricted share units. Restrictions lapse as follows: 594 shares on 7/2/2019, and 595 shares each on 7/2/2020 and 7/2/2021.
- F2The option represents a right to purchase a total of 7,516 shares, and is exercisable in three annual installments, with two installments of 2,505 shares each and one installment of 2,506 shares, beginning on July 2, 2019, which is the one-year anniversary of the option grant date.